New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Bluebird Bio's Thalassemia Gene Therapy Under Priority Review With FDA
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Bluebird Bio's Thalassemia Gene Therapy Under Priority Review With FDA
Bluebird Bio Files US Application For β-thalassemia Gene Therapy
Vertex Inks Potential $1.2B Gene-Editing Pact With Arbor Biotechnologies